Replies to post #106753 on Cytodyn Inc (CYDY)

[Venture_Cap]

It does, NP is wrong again.

Clinical trials should validate the news, not vice versa.

SP suffers as it’s unknown and NPs history while questionable is enough to hold back retail. Bad optics.

NP has never brought a drug to market and it’s not his background.

Bad time to have a rookie CEO and no plan. Even Dr. Yo said the only thing holding back leronlimab is a plan to execute.